Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619073 · ClinicalTrials.gov registry record · NA
PACT (Platelet Activity After Clopidogrel Termination)
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00619073 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 15 participants.
The verdict
NCT00619073, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Clopidogrel is a medication that is used to decrease the ability of platelets to form blood clots. The theory has been proposed that, in patients with coronary artery disease or stroke, increased platelet function after discontinuation of clopidogrel therapy is associated with an increased clotting risk. However, this theory has never been rigorously tested. The goal of this research is to determine whether discontinuation of clopidogrel results in increased platelet function.
Interventions
- DRUG placebo
- DRUG Aspirin
- DRUG clopidogrel + aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00619073
The ClinicalTrials.gov registry entry for NCT00619073 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00619073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00619073 about?
NCT00619073 is a clinical study titled "PACT (Platelet Activity After Clopidogrel Termination)". Clopidogrel is a medication that is used to decrease the ability of platelets to form blood clots. The theory has been proposed that, in patients with coronary artery disease or stroke, increased platelet function after discontinuation of clopidogrel therapy is associated with an increased clotting...
What is the current status of trial NCT00619073?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2008-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00619073?
The interventions under investigation include: placebo (DRUG), Aspirin (DRUG), clopidogrel + aspirin (DRUG).
Who is sponsoring clinical trial NCT00619073?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.